Iris Lansdorp-Vogelaar1, S Lucas Goede1, Jiemin Ma2, Wu Xiau-Cheng3, Karen Pawlish4, Marjolein van Ballegooijen1, Ahmedin Jemal2. 1. Department of Public Health, Erasmus MC, Rotterdam, the Netherlands. 2. Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia. 3. Louisiana Tumor Registry, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana. 4. Cancer Epidemiology Services, New Jersey Department of Health, Trenton, New Jersey.
Abstract
BACKGROUND: Northeastern states of the United States have shown more progress in reducing colorectal cancer (CRC) incidence and mortality rates than Southern states, and this has resulted in considerable disparities. This study quantified how the disparities in CRC rates between Louisiana (a Southern state) and New Jersey (a Northeastern state) would be affected if differences in risk factors, screening, and stage-specific CRC relative survival between the states were eliminated. METHODS: This study used the Microsimulation Screening Analysis Colon microsimulation model to estimate age-adjusted CRC incidence and mortality rates in Louisiana from 1995 to 2009 under the assumption that 1) Louisiana had the same smoking and obesity prevalence observed in New Jersey, 2) Louisiana had the same CRC screening uptake observed in New Jersey, 3) Louisiana had the same stage-specific CRC relative survival observed in New Jersey, or 4) all the preceding were true. RESULTS: In 2009, the observed CRC incidence and mortality rates in Louisiana were 141.4 cases and 61.9 deaths per 100,000 individuals, respectively. With the same risk factors and screening observed in New Jersey, the CRC incidence rate in Louisiana was reduced by 3.5% and 15.2%, respectively. New Jersey's risk factors, screening, and survival reduced the CRC mortality rate in Louisiana by 3.0%, 10.8%, and 17.4%, respectively. With all trends combined, the modeled rates per 100,000 individuals in Louisiana became lower than the observed rates in New Jersey for both incidence (116.4 vs 130.0) and mortality (44.7 vs 55.8). CONCLUSIONS: The disparities in CRC incidence and mortality rates between Louisiana and New Jersey could be eliminated if Louisiana could attain New Jersey's levels of risk factors, screening, and survival. Priority should be given to enabling Southern states to improve screening and survival rates.
BACKGROUND: Northeastern states of the United States have shown more progress in reducing colorectal cancer (CRC) incidence and mortality rates than Southern states, and this has resulted in considerable disparities. This study quantified how the disparities in CRC rates between Louisiana (a Southern state) and New Jersey (a Northeastern state) would be affected if differences in risk factors, screening, and stage-specific CRC relative survival between the states were eliminated. METHODS: This study used the Microsimulation Screening Analysis Colon microsimulation model to estimate age-adjusted CRC incidence and mortality rates in Louisiana from 1995 to 2009 under the assumption that 1) Louisiana had the same smoking and obesity prevalence observed in New Jersey, 2) Louisiana had the same CRC screening uptake observed in New Jersey, 3) Louisiana had the same stage-specific CRC relative survival observed in New Jersey, or 4) all the preceding were true. RESULTS: In 2009, the observed CRC incidence and mortality rates in Louisiana were 141.4 cases and 61.9 deaths per 100,000 individuals, respectively. With the same risk factors and screening observed in New Jersey, the CRC incidence rate in Louisiana was reduced by 3.5% and 15.2%, respectively. New Jersey's risk factors, screening, and survival reduced the CRC mortality rate in Louisiana by 3.0%, 10.8%, and 17.4%, respectively. With all trends combined, the modeled rates per 100,000 individuals in Louisiana became lower than the observed rates in New Jersey for both incidence (116.4 vs 130.0) and mortality (44.7 vs 55.8). CONCLUSIONS: The disparities in CRC incidence and mortality rates between Louisiana and New Jersey could be eliminated if Louisiana could attain New Jersey's levels of risk factors, screening, and survival. Priority should be given to enabling Southern states to improve screening and survival rates.
Authors: Esther M Stoop; Margriet C de Haan; Thomas R de Wijkerslooth; Patrick M Bossuyt; Marjolein van Ballegooijen; C Yung Nio; Marc J van de Vijver; Katharina Biermann; Maarten Thomeer; Monique E van Leerdam; Paul Fockens; Jaap Stoker; Ernst J Kuipers; Evelien Dekker Journal: Lancet Oncol Date: 2011-11-15 Impact factor: 41.316
Authors: John Oliver L DeLancey; Michael J Thun; Ahmedin Jemal; Elizabeth M Ward Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-11 Impact factor: 4.254
Authors: Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Rob Boer; Ann Zauber; J Dik F Habbema Journal: Cancer Date: 2009-06-01 Impact factor: 6.860
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer Journal: CA Cancer J Clin Date: 2008-03-05 Impact factor: 508.702
Authors: Ali H Mokdad; Laura Dwyer-Lindgren; Christina Fitzmaurice; Rebecca W Stubbs; Amelia Bertozzi-Villa; Chloe Morozoff; Raghid Charara; Christine Allen; Mohsen Naghavi; Christopher J L Murray Journal: JAMA Date: 2017-01-24 Impact factor: 56.272
Authors: M Solís-Ibinagagoitia; S Unanue-Arza; M Díaz-Seoane; L Martínez-Indart; A Lebeña-Maluf; I Idigoras; I Bilbao; I Portillo Journal: Front Public Health Date: 2020-12-11
Authors: Justin M Barnes; Kimberly J Johnson; Eric Adjei Boakye; Lidia Schapira; Tomi Akinyemiju; Eliza M Park; Evan M Graboyes; Nosayaba Osazuwa-Peters Journal: J Natl Cancer Inst Date: 2021-07-14 Impact factor: 11.816
Authors: Jaehyeong Cho; Seng Chan You; Seongwon Lee; DongSu Park; Bumhee Park; George Hripcsak; Rae Woong Park Journal: Int J Environ Res Public Health Date: 2020-10-26 Impact factor: 3.390